Revumenib Citrate

CAT: 0931-MF-0111932-01Size: 10 mgDry Ice: NoHazardous: No
CAT#:0931-MF-0111932-01Size:10 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
CAS Number
2761046-45-9
Bioactivity
Revumenib (also known as SNDX-5613) is an effective and selective Menin-MLL inhibitor. It is primarily used for the study of MLL-rearranged (MLL-r) acute leukemias, including acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) .
Smiles
C(CC(O)=O)(CC(O)=O)(C(O)=O)O.C(N1CCC2(CN(C2)C=3C(OC4=C(C(N(C(C)C)CC)=O)C=C(F)C=C4)=CN=CN3)CC1)[C@@H]5CC[C@@H](NS(CC)(=O)=O)CC5.O
Molecular Formula
C38H57FN6O12S
Molecular Weight
840.96
Shipping Conditions
Cool pack
Storage Temperature
-20°C

Related Products

CatalogName
MF-0161310TRIMETHYL CITRATE
MF-0151590-01Carfentanil citrate
MF-0138409-01Isoaminile citrate
MF-0036251-01Elzasonan citrate
MF-0127748-01Citrate synthase
MF-0147940-01Butamirate citrate
MF-0017063-01Ixazomib citrate
MF-0014181-01Tandospirone citrate
MF-0031433-01Zuclomiphene citrate
MF-0005173-01Diethylcarbamazine citrate

Alternative Products

CatalogName
C8689-1Revumenib
S8996-5mgRevumenib (SNDX-5613)
A22526-25Revumenib (SNDX-5613) 25mg
A22526-1Revumenib (SNDX-5613) 1mg
A22526-2Revumenib (SNDX-5613) 2mg
A22526-10mM-DRevumenib (SNDX-5613) 10mM * 1mL in DMSO
MBS653895-01Citrate Synthase (Citrate Condensing Enzyme, Citrate Oxaloacetate Lyase)
YLA3901HU-01Human citrate (citrate) ELISA Kit
MBS6025278-01CP-690550 Citrate (Tofacitinib Citrate)
MBS132416-01Tofacitinib citrate (CP-690550 citrate)

Popular Products